Diovan Hct
NDC 68258-6973
Product Information
Diovan Hct is a NDA-approved product labeled by Dispensing Solutions, Inc.. This drug is used to treat high blood pressure. It is supplied as a red product. This product entry covers the primary NDC 68258-6973 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
BROWN (C48332 - BROWN ORANGE)
14 MM
CG;HHH
NVR;HXH
Code Structure Chart
Product Details
What is NDC 68258-6973?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- VALSARTAN (UNII: 80M03YXJ7I)
- VALSARTAN (UNII: 80M03YXJ7I) (Active Moiety)
- HYDROCHLOROTHIAZIDE (UNII: 0J48LPH2TH)
- HYDROCHLOROTHIAZIDE (UNII: 0J48LPH2TH) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
- CROSPOVIDONE (UNII: 68401960MK)
- HYPROMELLOSES (UNII: 3NXW29V3WO)
- FERRIC OXIDE RED (UNII: 1K09F3G675)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
- POLYETHYLENE GLYCOLS (UNII: 3WJQ0SDW1A)
- TALC (UNII: 7SEV7J4R1U)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 200285 - valsartan 160 MG / hydroCHLOROthiazide 12.5 MG Oral Tablet
- RxCUI: 200285 - hydrochlorothiazide 12.5 MG / valsartan 160 MG Oral Tablet
- RxCUI: 200285 - HCTZ 12.5 MG / valsartan 160 MG Oral Tablet
- RxCUI: 349353 - valsartan 160 MG / hydroCHLOROthiazide 25 MG Oral Tablet
- RxCUI: 349353 - hydrochlorothiazide 25 MG / valsartan 160 MG Oral Tablet
* Please review the full disclaimer at the bottom of this page.